Coca-Cola Europacific Eyes Takeover of Coca-Cola's $1.8 Billion Philippines Bottling Business
By Joe Hoppe
Coca-Cola Europacific Partners said Wednesday that it is considering together with Aboitiz Equity Ventures to buy Coca-Cola Beverages Philippines from The Coca-Cola Company, valuing it at around $1.8 billion.
The London-listed bottling company said the Philippines bottling business shows attractive profitability and growth prospects, and would build upon its own expansion into the Australia, Pacific and Indonesia market that started 2021.
A takeover would be expected to close around the end of 2023. It is still subject to a number of conditions, including due diligence and regulatory approval, and there can be no certainty it will be entered into nor completed, it said.
The European bottler said it has entered a letter of intent and signed a nonbinding term sheet with AEV on the potential joint transaction, based on a 60:40 ownership structure for Coca-Cola Europacific and AEV, respectively.
The agreement implies an enterprise value of $1.8 billion on a debt-free, cash-free basis for the Philippines business. The consideration would be paid in cash.
The proposed acquisition would position Coca-Cola Europacific as the world's largest Coca-Cola bottler by both revenue and volume.
Write to Joe Hoppe at joseph.hoppe@wsj.com
(END) Dow Jones Newswires
August 02, 2023 03:32 ET (07:32 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast